Breakthrough HIV Vaccine Demonstrates Remarkable Preclinical Efficacy

A novel HIV vaccine demonstrated exceptional efficacy in preclinical trials by inducing high levels of broadly neutralizing antibodies in non-human primates. Human clinical trials have commenced following this breakthrough in vaccine development.

Comments

Read original article